Home > Healthcare > Pharmaceuticals > Disease Specific Drugs > Anti-acne Dermal Patch Market
The anti-acne dermal patch market by type is categorized into chemical based, and herbal based. The herbal based segment garnered USD 198.1 million revenue size in the year 2022. In recent years, there has been rising trend towards natural and holistic approaches to skincare and health. Consumers are increasingly seeking products that contain natural ingredients and are perceived as gentler on the skin. Natural acne patches are made from readily available materials such as silk and mulberries, that help in fast healing of acne. Herbal-based anti-acne dermal patches can potentially be formulated with different herbal combinations to cater to various skin types and concerns. This customization aligns with the growing demand for personalized skincare solutions.
Based on age group, the anti-acne dermal patch market is segmented into 10 to 17, 18 to 44, 45 to 64, 65+. The 18 to 44 age group accounted for over 52% industry share in the year 2022. The youth's self-confidence and self-esteem are increasing as a result of growing care related to their physical appearance. Cryotherapy and medical laser therapy are two of the many alternatives on the business for treating and preventing acne. However, due to their low cost, short preparation time, and outstanding outcomes, products such as anti-acne dermal patches are anticipated to grow by 2032
Based on distribution channel, the anti-acne dermal patch market is segmented into pharmacies & drug stores, e-commerce platform, retail stores. The pharmacies & drug stores segment accounted for over 46% industry share in the year 2022 attributable to the rising popularity of OTC products from drug stores and pharmacies for the self-management of skin conditions such as acne. For instance, according to a survey performed by the University Clinic for Dermatology and Venereology among pharmacies throughout Germany, more than 35% of patients choose to treat their mild acne on their own with over the counter (OTC) treatments.
U.S. anti-acne dermal patch market accounted for USD 112.6 million revenue size in 2022. The U.S. dominance in the industry is primarily attributed to its highly advanced and well-established healthcare infrastructure, coupled with rising number of companies expanding their business across lucrative industry. Furthermore, factors such as changing consumer preferences towards natural and convenient skincare solutions, as well as an increasing emphasis on personalized skincare, contributed to the development of industry in the U.S. Additionally, the widespread occurrence of acne creates a substantial business demand for effective solutions, including dermal patches.